Benefits
Hepatoprotective Activity (Animal Evidence)
The Hewawasam 2003 mouse study showed significant protection against carbon tetrachloride and paracetamol hepatotoxicity — ALT reduced by 69.32%, liver glutathione increased by 64.65%. Histopathological improvement supported biochemical findings. This is the strongest preclinical signal but has not been replicated in human trials.
Traditional Use for Urinary Tract Conditions
Used in Ayurveda for urinary disorders, kidney stones, and dropsy (edema). The Ingale 2012 rat study showed effects in ethylene glycol-induced nephrolithiasis. Diuretic and anti-urolithic effects are documented in animal models; human clinical evidence is limited.
Erythropoietic / Hematopoietic Activity
Animal studies (Pawar 2010) showed seed extract significantly increased red blood cell count, hemoglobin, serum iron, and serum protein in rats. Iron content of the plant may contribute to traditional use as a 'tonic' for general weakness and anemia. No human RCT confirmation.
Anti-inflammatory / Antipyretic (Animal)
Patra 2009 leaf studies in animal models demonstrated anti-inflammatory and antipyretic activities, consistent with traditional Ayurvedic use for fever, swelling, and rheumatic conditions. Human clinical translation is absent.
Antioxidant Activity
In vitro and animal studies show antioxidant effects via phenolic compounds and flavonoids. The hepatoprotection observed in animals likely reflects this antioxidant capacity, particularly via glutathione preservation under oxidative stress.
Mechanism of action
Glutathione Preservation
The Hewawasam 2003 study documented 64.65% increase in liver glutathione (GSH) with Asteracantha treatment under CCl4 hepatotoxicity. GSH is the master cellular antioxidant; its preservation is a key mechanism for liver protection against oxidative xenobiotic stress.
Free Radical Scavenging
Phenolic compounds and flavonoids (apigenin-7-O-glucuronide, lupeol-related triterpenes) scavenge reactive oxygen species in vitro. This contributes to antioxidant, anti-inflammatory, and tissue-protective effects across multiple animal models.
Diuretic Effect
Traditional indication for urinary disorders is supported by animal diuretic studies. Mechanism likely involves potassium-sparing diuresis via mineral content and possibly aquaporin-related effects, though not fully characterized.
Possible Hormonal/Reproductive Effects
Some animal studies suggest effects on reproductive hormones and sperm parameters in male rats. The mechanism is unclear — possibly via mild androgenic activity from the steroid sapogenins. Not validated in human trials; treat as exploratory.
Iron Content and Erythropoietic Support
Plant content of iron and other minerals may underlie traditional use as a 'tonic' for general weakness. The Pawar 2010 rat study documented increased serum iron alongside RBC and hemoglobin elevation, suggesting both nutritional iron contribution and possible erythropoietin-related effects.
Clinical trials
Mouse model of CCl4- and paracetamol-induced acute hepatotoxicity. Aqueous whole-plant extract (0.9 g/kg) used pre- and post-treatment. Liver function tests, glutathione, and histopathology assessed. (Hewawasam, Jayatilaka, Pathirana, Mudduwa 2003, J Pharm Pharmacol)
Mice (in vivo). NO human data.
Asteracantha reduced ALT 69.32% (p<0.001) and increased liver glutathione 64.65% (p<0.001) in pre-treated CCl4 group at 4 days. Similar protective pattern with paracetamol — ALT, AST, ALP reduced by 65.04%, 55.79%, 45.75% respectively. Histopathology confirmed marked improvement in liver architecture. Foundational preclinical evidence; NOT a human trial.
Rat model of ethylene glycol-induced nephrolithiasis evaluating Hygrophila spinosa extract. Outcomes: stone formation, kidney histology, biochemical markers. (Ingale, Thakurdesai, Vyawahare 2012, Indian J Pharmacol)
Rats with experimentally-induced kidney stones. NO human data.
Demonstrated anti-urolithic activity supporting traditional Ayurvedic use for kidney stones and urinary tract conditions. Mechanism may involve modulation of oxalate metabolism and urinary citrate/calcium ratios. Animal data only — no human clinical trials of Asteracantha for kidney stones exist.
About this ingredient
Asteracantha longifolia (synonyms Hygrophila spinosa, Hygrophila auriculata) is a herb in the Acanthaceae family, native to wetlands of South and Southeast Asia. Vernacular names include Talimkhana, Gokulakanta, and Nirmulli. Traditional Ayurvedic and Siddha uses include treatment of liver disorders, kidney stones, urinary issues, dropsy (edema), rheumatism, anemia, and weakness.
Bioactives include lupeol and betulin (triterpenes), stigmasterol, apigenin-7-O-glucuronide and other flavonoids, alkaloids, and a fatty oil rich in linoleic acid. EVIDENCE: Almost entirely preclinical. Hepatoprotection (Hewawasam 2003), anti-urolithic activity (Ingale 2012), erythropoietic effects (Pawar 2010), and antiinflammatory activity (Patra 2009) are well-documented in animal models.
**Human clinical trials are essentially absent**. The 1999 Thankamma rheumatoid arthritis report (PMID 22556897) was a brief Anc Sci Life note. SAFETY: Limited modern data.
Generally well-tolerated traditionally. Pregnancy: avoid. NOT a substitute for evidence-based liver, kidney, or anemia treatments — discuss with a physician for clinical concerns.